Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The history of the oxazaphosphorine cytostatics.
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
White matter astrocytes in health and disease.
Pregnancy outcomes in female patients and partners of male patients in the teriflunomide clinical development program.
CNS myelin wrapping is driven by actin disassembly.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Health Canada Approves PLEGRIDY™ (peginterferon beta-1a) for Adults with Relapsing Remitting Multiple Sclerosis
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy.
Multiple sclerosis.
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
Fingolimod modulates microglial activation to augment markers of remyelination.
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
Fingolimod phosphate promotes the neuroprotective effects of microglia.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Prevention and treatment of MS: studying the effects of vitamin D.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Centocor briefing document for Ustekinumab, submitted to FDA
Demyelination affects temporal aspects of perception: An optic neuritis study.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Pages
« first
‹ previous
…
92
93
94
95
96
97
98
99
100
…
next ›
last »